FDA Inspection 1315898 — Bachem Americas, Inc.

Bachem Americas, Inc. — FEI 2024023

The FDA completed an inspection of Bachem Americas, Inc. on May 4, 2026 in Torrance, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 4, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)